IDO1 and neoplasm: The purpose of this study is to digitally quantify TAM abundance and to characterize TAM immunophenotypes with regard to PD-L1 and IDO-1 expression from diagnostic cHL tumor samples, as well as to associate the findings with clinical characteristics and survival.